Hematuria News and Research

RSS
In medicine, hematuria, or haematuria, is the presence of red blood cells (erythrocytes) in the urine. It may be idiopathic and/or benign, or it can be a sign that there is a kidney stone or a tumor in the urinary tract (kidneys, ureters, urinary bladder, prostate, and urethra), ranging from trivial to lethal.
Assessing the association of COVID-19 and Immunoglobulin A vasculitis in children

Assessing the association of COVID-19 and Immunoglobulin A vasculitis in children

Study evaluates the potential benefits of mass dipstick screening to detect hematuria

Study evaluates the potential benefits of mass dipstick screening to detect hematuria

Urine sampling not to be restricted to children with unexplained fever, say researchers

Urine sampling not to be restricted to children with unexplained fever, say researchers

Immunomodulatory therapies for nephrological autoimmune diseases may help treat severe COVID-19

Immunomodulatory therapies for nephrological autoimmune diseases may help treat severe COVID-19

COVID-19 can cause long-term consequences for the kidneys

COVID-19 can cause long-term consequences for the kidneys

UroCAD assay is better than urine cytology in detecting bladder cancer

UroCAD assay is better than urine cytology in detecting bladder cancer

Indirect viral infection of the kidneys by SARS-CoV-2-induced inflammatory reaction

Indirect viral infection of the kidneys by SARS-CoV-2-induced inflammatory reaction

Kidney impairment significantly higher among hospitalized COVID-19 patients

Kidney impairment significantly higher among hospitalized COVID-19 patients

Treating hospitalized COVID-19 patients with anticoagulants may improve their survival chances

Treating hospitalized COVID-19 patients with anticoagulants may improve their survival chances

Innovative approach offers kidney-sparing treatment option for upper tract urothelial cancer

Innovative approach offers kidney-sparing treatment option for upper tract urothelial cancer

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

NeoTract presents new clinical data from studies of UroLift System for patients with BPH

NeoTract presents new clinical data from studies of UroLift System for patients with BPH

CNDA approves KEYTRUDA for treatment of advanced melanoma

CNDA approves KEYTRUDA for treatment of advanced melanoma

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

NeoTract announces results of study measuring costs and patient outcomes of UroLift System

NeoTract announces results of study measuring costs and patient outcomes of UroLift System

AUA recommends use of UroLift System for managing lower urinary tract symptoms attributed to BPH

AUA recommends use of UroLift System for managing lower urinary tract symptoms attributed to BPH

New article explores cost-effectiveness of initial diagnostic protocols for microscopic hematuria

New article explores cost-effectiveness of initial diagnostic protocols for microscopic hematuria

Pacific Edge announces commercial launch of Cxbladder Monitor in the U.S.

Pacific Edge announces commercial launch of Cxbladder Monitor in the U.S.